Back to today’s briefing

Story perspectives

Blocking SPP1 Could Halt Aggressive Pancreatic Cancer Spread

9/25/2025

50 11

Summary

Story summary

Researchers at The Institute of Cancer Research in London found blocking SPP1 may stop pancreatic cancer spread.
Pancreatic ductal adenocarcinoma (PDAC) is the UK's most common, aggressive pancreatic cancer with over 11,000 diagnoses annually.
Survival remains low; over half die within three months.
Higher SPP1 levels correlate with worse outcomes; blocking SPP1 raises GREM1, which may reduce spread.

1 of 1

Story summary

Researchers at The Institute of Cancer Research in London found blocking SPP1 may stop pancreatic cancer spread.
Pancreatic ductal adenocarcinoma (PDAC) is the UK's most common, aggressive pancreatic cancer with over 11,000 diagnoses annually.
Survival remains low; over half die within three months.
Higher SPP1 levels correlate with worse outcomes; blocking SPP1 raises GREM1, which may reduce spread.